Anti-CD119 antibody (26-250 aa) (STJ11105176)

SKU:
STJ11105176
£110.50 - £505.50
Processing The item has been added

Short Description :Rabbit polyclonal CD119 (26-250 aa) antibody for use in WB and ELISA in mouse samples. Datasheet included with dilution recommendations, and related reagents.
Applications:WB/ELISA
Host:Rabbit
Reactivity:Mouse
Note:STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality :Polyclonal
Isotype:IgG
Conjugation:Unconjugated
Concentration:Lot specific
Purification:Affinity purification
Dilution Range:WB:1:1000-1:5000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Formulation:PBS with 0.05% Proclin300, 50% Glycerol, pH 7.3.
Storage Instruction:Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol:Ifngr1
Gene ID:15979
Uniprot ID:INGR1_MOUSE
Immunogen Region:26-250 aa
Immunogen Sequence:ALTSTEDPEPPSVPVPTNVL IKSYNLNPVVCWEYQNMSQT PIFTVQVKVYSGSWTDSCTN ISDHCCNIYEQIMYPDVSAW ARVKAKVGQKESDYARSKEF LMCLKGKVGPPGLEIRRKKE EQLSVLVFHPEVVVNGESQG TMFGDGSTCYTFDYTVYVEH NRSGEILHTKHTVEKEECNE TLCELNISVSTLDSRYCISV DGISSFWQVRTEKSKDVCIP PFHDD
Specificity:Recombinant fusion protein containing a sequence corresponding to amino acids 26-250 of mouse CD119. (NP_034641.1).
Post Translational Modifications Phosphorylated at Ser/Thr residues. Phosphorylation of Tyr-445 is required for IFNG receptor signal transduction. Influenza virus infection leads to phosphorylation in a CSNK1A1-dependent manner. Ubiquitinated after phosphorylation in a CSNK1A1-dependent manner, leading to the lysosome-dependent degradation. Proteasomally degraded through 'Lys-48'-mediated ubiquitination. Ubiquitination is necessary for efficient IFNGR1 signaling.
Function Receptor subunit for interferon gamma/INFG that plays crucial roles in antimicrobial, antiviral, and antitumor responses by activating effector immune cells and enhancing antigen presentation (, PubMed:20926559, PubMed:27286456). Associates with transmembrane accessory factor IFNGR2 to form a functional receptor. Upon ligand binding, the intracellular domain of IFNGR1 opens out to allow association of downstream signaling components JAK1 and JAK2. In turn, activated JAK1 phosphorylates IFNGR1 to form a docking site for STAT1. Subsequent phosphorylation of STAT1 leads to its dimerization, translocation to the nucleus, and stimulation of target gene transcription. STAT3 can also be activated in a similar manner although activation seems weaker. IFNGR1 intracellular domain phosphorylation also provides a docking site for SOCS1 that regulates the JAK-STAT pathway by competing with STAT1 binding to IFNGR1.
Protein Name Interferon Gamma Receptor 1
Ifn-Gamma Receptor 1
Ifn-Gamma-R1
Interferon Gamma Receptor Alpha-Chain
Ifn-Gamma-R-Alpha
Cd Antigen Cd119
Database Links Reactome: R-MMU-877300
Reactome: -MMU-877312
Reactome: -MMU-9732724
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Alternative Antibody Names Anti-Interferon Gamma Receptor 1 antibody
Anti-Ifn-Gamma Receptor 1 antibody
Anti-Ifn-Gamma-R1 antibody
Anti-Interferon Gamma Receptor Alpha-Chain antibody
Anti-Ifn-Gamma-R-Alpha antibody
Anti-Cd Antigen Cd119 antibody
Anti-Ifngr1 antibody
Anti-Ifngr antibody

Information sourced from Uniprot.org